Medicine | Penn Today

Aerial view of Penn Medicine Doylestown’s campus.

News

Doylestown Health joins University of Pennsylvania Health System

The Bucks County system’s integration into UPHS will expand access to advanced health care for patients and families in the suburbs of Philadelphia.

News

Meniscus injuries may soon be treated by customizable hydrogel

Researchers at the Perelman School of Medicine found a new 3D-printed customizable hydrogel performed well in preclinical trials with several different types of meniscal tears, offering a potential mend for common joint injuries.

Measles: An explainer

Judy O’Donnell, the associate chief medical officer for Healthcare Epidemiology for the University of Pennsylvania Health System, and the chief of Infectious Diseases at Penn Presbyterian Medical Center, explains what people need to know about measles.

The New York Times

Drug reduces mysterious particle involved in heart attack risk

Daniel Rader of the Perelman School of Medicine says that lowering levels of the Lp(a) particle represents a huge new frontier in cardiovascular medicine.

New technology is poised to bring gene therapy to common chronic diseases

New research from Penn Medicine reveals a safe delivery system of DNA-loaded lipid nanoparticles directly to cells, which could transform treatment for common chronic diseases like heart disease, diabetes, and cancer.

2 min. read

Headshots of five Penn professors elected 2024 AAAS Fellows.

Five from Penn elected 2024 AAAS Fellows

Professors from the School of Arts & Sciences, Perelman School of Medicine, and School of Engineering and Applied Science are among 471 scientists, engineers, and innovators being recognized by the American Association for the Advancement of Science.

4 min. read

Allyson Mackey, Melissa Kelly, Ping Wang, and Vanessa Chan speaking to audience.

Modeling careers in STEM

At Penn’s annual Women in STEM Symposium, Vanessa Chan, Allyson Mackey, Ping Wang, and Melissa Kelly shared lessons from their experiences.

3 min. read

Immunotherapy may boost KRAS-targeted therapy in pancreatic cancer

A preclinical study from the Perelman School of Medicine and Penn Medicine’s Abramson Cancer Center that combines RAS inhibition and immunotherapy shows promise for future clinical trials in pancreatic cancer treatment strategies.

1 min. read

Anti-obesity medication boosts weight loss when behavioral therapy falls short

Adding an anti-obesity medication just one month after behavioral therapy begins—rather than waiting the currently recommended six months—can more than double weight loss for patients who struggle initially with lifestyle changes alone, according to new research published in Nature Medicine from a team at the Perelman School of Medicine.